Mutascreen is an automated instrument for bacterial mutagenicity testing. The biological principles of the Mutascreen assay are the same as those of the bacterial reverse-mutation assays, like the Ames test, but several operational principles are different. The Mutascreen assay takes place in wells containing only 400 microliter of liquid medium. Also, the dispensing of the liquid medium, the bacterial tester strains, the metabolic activation system (S9), and the test solutions is all performed by a computer-controlled robot according to the user's preprogrammed instructions. The turbidity in up to 200 wells is monitored intermittently over a 24-h period by a vertical-pathway photometer, thereby avoiding measurement problems caused by sedimentation. The data for the resulting growth curves is stored for analysis. The auxotrophic growth pattern is altered characteristically by test solutions that are toxic or contain endogenous growth factor(s), while prototrophic growth is observed earlier in the 24-h period when revertants have been induced by the test solution. To compare the Mutascreen assay with the conventional plate assay, 36 chemicals including known carcinogens and noncarcinogens were tested. Both assays identified the same chemicals as mutagens and gave quantitatively similar results, thus testifying to the potential usefulness of automated bacterial mutagenicity testing.

Automation↗

PubMedDate not supplied

Application of a semi-automated SOS chromotest for measuring genotoxicities of complex environmental mixtures containing polycyclic aromatic hydrocarbons.

Soxhlet-extracted samples of standard reference materials (SRMs) 1649 (PAR1: urban dust/organics) and 1650 (PAR2: diesel particulate matter) from the U.S. Institute of Standards and Technology were tested for induction of SOS functions using a semi-automated version of the SOS chromotest with Escherichia coli PQ37. Concentrations of 10 polycyclic aromatic hydrocarbons in the extracts were determined using reversed-phase HPLC. Only the diesel particulate matter (PAR2) extracts expressed SOS induction activity, which decreased when metabolic activation was used. Mutagenic PAH compounds (e.g., chrysene) were found in higher concentrations in the PAR2 extracts than in the PAR1 extracts but this could not explain the genotoxicity while it was mainly exhibited without metabolic activation. The direct genotoxic activity of the diesel particulate matter sample PAR2 is probably caused by nitroaromatic compounds; this was also supported by parallel studies with the Ames/Salmonella assay.

Air Pollutants↗

PubMedDate not supplied

The parallelogram approach in studies of genotoxic effects.

Over the past two decades mutagenicity tests have been used for the identification of potential human mutagens and have had an ancillary role, as supportive evidence in the assessment of human carcinogens. The demonstration of human germinal mutagens has been beyond the main scope of short-term testing strategies. However, just as mutagenicity tests have been useful in detecting potential carcinogens so should carcinogenicity tests assist the identification of presumptive germ cell mutagens. Cancer is an easily observable phenotype of mutation for genotoxic carcinogens and multi-site carcinogens or gonadal carcinogens logically could be germ cell mutagens. Thus carcinogenicity and mutagenicity data for a given genotoxic chemical should be considered together in the identification of putative germinal mutagens. Clearly, most classified human carcinogens are genotoxic thus helping to build the case for human germ cell mutagenicity. This paper describes the issues involved in such thinking and suggests an enhanced parallelogram approach incorporating the cancer endpoint. The enhanced parallelogram is explored using 1,3-butadiene and ethylene oxide as examples. The obvious lack of data for extrapolations using the parallelogram method suggests the need for targeted studies specifically designed for use in this approach.

Animals↗

PubMedDate not supplied

Sister-chromatid exchanges in lymphocytes of smokers in an experimental study.

The frequency of sister-chromatid exchanges (SCEs) was studied in peripheral blood lymphocytes of 26 young male smokers and 10 non-smokers who had recently entered military service. The levels of SCEs were examined in 4 consecutive blood samples taken after short experimental periods of smoking only low-tar (LT) or medium-tar (MT) cigarettes. The incidence of SCEs was significantly higher in the the group of smokers than in the group of non-smokers. The SCE levels of the smokers were found to be associated with the personal smoking history; the observed increase in the SCE frequency correlated with the years of smoking measured as cumulative pack years. The difference in type of cigarette did not influence the SCE frequencies.

Adolescent↗

PubMedDate not supplied

Somatic mutation theory.

The evidence is reviewed that supports the role of genetic lesions in carcinogenesis; such lesions may be initiating events in the multistep process leading to clinically detectable tumor. Other possible manifestations of alterations in the hereditary material of somatic cells are discussed; DNA damage may lead to benign tumors responsible for atherosclerosis, to neurological deterioration, and to senescence of the individual. During embryonal development, transplacental mutagens may cause somatic mosaicism in the fetus, which may manifest as congenital malformations, spontaneous abortions, and childhood cancers.

Aging↗

PubMedDate not supplied

Cytogenetic methods in the detection of chemical carcinogens.

Cytogenetic techniques may be used to detect genetic damage caused by environmental agents in eukaryotes. The significance of in vitro and in vivo assays for chromosome damage, sister chromatid exchange frequency, and occurrence of micronuclei is discussed in connection with their suitability for screening. Cytogenetic methods can also be used to monitor chromosomal changes in somatic cells of exposed groups of people, and they may have diagnostic and prognostic value in human neoplasms.

Bone Marrow Cells↗